Literature DB >> 15566365

Somatic deletion of the normal beta-globin gene leading to thalassaemia intermedia in heterozygous beta-thalassaemic patients.

Renzo Galanello1, Lucia Perseu, Chiara Perra, Liliana Maccioni, Susanna Barella, Maurizio Longinotti, Antonio Cao, Mario Cazzola.   

Abstract

Two beta-thalassaemia patients, whose constitutive genotype was beta(39C)/beta(39C-->T), had the clinical phenotype beta-thalassaemia intermedia. Analysis of leucocyte DNA showed the presence of the mutated beta(39C-->T)-gene exclusively, while the normal beta(39C)-gene was also present in reticulocyte RNA. Deletional analysis of chromosome 11p15.5 on leucocyte DNA showed large deletions including the beta-globin gene. Two populations of erythroid progenitors, one heterozygous and the other hemizygous for the beta(39C-->T) mutation, were demonstrated in one case. This confirms that, in heterozygous individuals, beta-thalassaemia intermedia may be caused by inactivation of the beta-locus in trans as a result of chromosome 11p15.5 deletions in a subpopulation of haematopoietic cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15566365     DOI: 10.1111/j.1365-2141.2004.05237.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

1.  HBB loss of heterozygosity in the hemopoietic lineage gives rise to an unusual sickle-cell trait phenotype.

Authors:  Philippe Joly; Caroline Schluth-Bolard; Philippe Lacan; Claire Barro; Serge Pissard; Audrey Labalme; Damien Sanlaville; Catherine Badens
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

Review 2.  Molecular basis of β thalassemia and potential therapeutic targets.

Authors:  Swee Lay Thein
Journal:  Blood Cells Mol Dis       Date:  2017-06-20       Impact factor: 3.039

3.  Myelodysplastic syndrome associated with acquired beta thalassemia: "BTMDS".

Authors:  Andrew M Brunner; David P Steensma
Journal:  Am J Hematol       Date:  2016-07-04       Impact factor: 10.047

4.  Mosaic segmental uniparental isodisomy and progressive clonal selection: a common mechanism of late onset β-thalassemia major.

Authors:  Cornelis L Harteveld; Chiara Refaldi; Antonino Giambona; Claudia A L Ruivenkamp; Mariëtte J V Hoffer; Jeroen Pijpe; Peter De Knijff; Caterina Borgna-Pignatti; Aurelio Maggio; Maria D Cappellini; Piero C Giordano
Journal:  Haematologica       Date:  2012-09-14       Impact factor: 9.941

5.  Association of α globin gene quadruplication and heterozygous β thalassemia in patients with thalassemia intermedia.

Authors:  Maria Carla Sollaino; Maria Elisabetta Paglietti; Lucia Perseu; Nicolina Giagu; Daniela Loi; Renzo Galanello
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

Review 6.  The molecular basis of β-thalassemia.

Authors:  Swee Lay Thein
Journal:  Cold Spring Harb Perspect Med       Date:  2013-05-01       Impact factor: 6.915

Review 7.  The hemoglobinopathies, molecular disease mechanisms and diagnostics.

Authors:  Cornelis L Harteveld; Ahlem Achour; Sandra J G Arkesteijn; Jeanet Ter Huurne; Maaike Verschuren; Sharda Bhagwandien-Bisoen; Rianne Schaap; Linda Vijfhuizen; Hakima El Idrissi; Tamara T Koopmann
Journal:  Int J Lab Hematol       Date:  2022-09       Impact factor: 3.450

8.  β Thalassemia major due to acquired uniparental disomy in a previously healthy adolescent.

Authors:  Celeste Bento; Tabita M Maia; Jelena D Milosevic; Isabel M Carreira; Robert Kralovics; M Leticia Ribeiro
Journal:  Haematologica       Date:  2012-08-08       Impact factor: 9.941

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.